BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
7 September 2026
No Comments
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present new clinical data from its